Search

everythinglearnresearchcommunity

for

Search:↓

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Women with PCOS have distinct clinical and hormonal differences, requiring thorough evaluation for proper diagnosis and management.

Pediatric androgenetic alopecia is linked to obesity, family history, hormonal imbalances, and requires personalized treatment including managing comorbidities.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Sansevieria trifasciata P. extracts, especially the ethyl acetate fraction, effectively promote hair growth in male rabbits with hair loss.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Sex hormone therapy is effective for certain skin conditions like acne and seborrhea, but less so for female hair loss and excessive hair growth.

Many women with PCOS have hair loss, linked to age, hirsutism, sleep issues, and smoking.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Male hormones and reduced plakoglobin can impair heart electrical function and increase arrhythmia risk in males.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Male pattern baldness is mainly caused by a hormone called dihydrotestosterone (DHT), and drugs that can block this hormone might help prevent hair loss.

New understanding of hair loss could lead to better treatments.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Metformin reduces certain hormone levels in men with early-onset hair loss.

The HSD3B1 variant increases hair loss risk in overweight women with PCOS.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Hair loss, known as androgenetic alopecia, is mainly caused by genetics, but also by hormone imbalances, shrinking hair follicles, inflammation, and environmental factors.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.